Search - tctmd.com

Displaying 141 - 154 of 154

Sort: Relevancy | Date

CLASP 2-Year Data Promising for Pascal Transcatheter Mitral RepaiR

News Conference News EuroPCR 2021

CLASP 2-Year Data Promising for Pascal Transcatheter Mitral Repair

May 19, 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

News Conference News ACC 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

May 18, 2021

Surgery After Failed Mitral Edge-to-Edge Repair Tends to Be Replacement

News Daily News

Surgery After Failed Mitral Edge-to-Edge Repair Tends to Be Replacement

May 05, 2021

For Failed MitraClip, Next Procedure Might Depend on MR Etiology

News Daily News

For Failed MitraClip, Next Procedure Might Depend on MR Etiology

April 23, 2021

CMS Extends MitraClip Coverage to Functional MR, Carves Out Imager Role

News Daily News

CMS Extends MitraClip Coverage to Functional MR, Carves Out Imager Role

January 20, 2021

CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures

News Conference News PCR London Valves 2020

CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures

November 24, 2020

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

News Conference News AHA 2020

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

November 13, 2020

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

News Daily News

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

July 01, 2020

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

September 16, 2019

RELAX-AHF-2: Lack of Benefit With Serelaxin in Acute HF Still a Puzzle for Investigators

News Daily News

RELAX-AHF-2: Lack of Benefit With Serelaxin in Acute HF Still a Puzzle for Investigators

August 21, 2019

News Daily News

依泽替米贝减少心血管事件的说法未能获得 FDA 顾问委员会的支持

Michael O'Riordan

December 15, 2015

News Daily News

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Michael O'Riordan

December 15, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Industry News

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

May 23, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.